Identification and assessment of new vaccine candidates for group A streptococcal infections

Vaccine
David J McMillanMagnus Rasmussen

Abstract

Group A Streptococcus (GAS) is a human-specific pathogen responsible for a wide variety of human diseases. Numerous GAS surface antigens interact with the human immune system and only some of these proteins have been studied in depth. A few of these may elicit protective response against GAS infection. In this study, we have used an in silico approach to identify antigenic peptides from GAS surface proteins. Putative GAS surface proteins from the M1 GAS genome were identified by the presence on LPxTG cell-wall anchoring motif and an export signal sequence. This technique identified 17 proteins of known or putative function, and another 11 which do not have known homologues. Peptides derived from predicted antigenic sequences near the amino terminus of six of these proteins, and another seven peptides derived from the two known surface proteins, GRAB and MtsA, were conjugated to keyhole lymphocyanin (KLH), and investigated for their capacity to induce opsonic antibody responses in outbred Quackenbush mice. All peptide-KLH antisera demonstrated opsonic capacity against both 88/30 and M1 GAS. However, KLH sera alone was also able to induce opsonic antibodies, suggesting that anti-KLH antibodies contributed to the opsonisation seen...Continue Reading

References

Nov 1, 1986·Scandinavian Journal of Immunology·M Yarnall, M D Boyle
Jun 1, 1995·Molecular Immunology·M D BoyleA Podbielski
May 23, 1998·Journal of Clinical Microbiology·D L GardinerK S Sriprakash
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
Jun 22, 1999·Immunologic Research·E R Brandt, M F Good
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·J J FerrettiR McLaughlin
Mar 16, 2002·Infection and Immunity·Mary C HuJames B Dale
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·James C SmootJames M Musser
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Stephen B BeresJames M Musser
Mar 7, 2003·Clinical Breast Cancer·Nuhad K Ibrahim, James Lee Murray

❮ Previous
Next ❯

Citations

Jun 2, 2006·PLoS Medicine·Simon C WagstaffRobert A Harrison
Mar 4, 2006·Current Opinion in Infectious Diseases·Bart J Currie
Oct 3, 2009·Current Opinion in Infectious Diseases·Andrew C SteerJonathan R Carapetis
Jan 22, 2005·Annual Review of Medicine·Claire M Fraser, Rino Rappuoli
Jun 6, 2009·Expert Review of Proteomics·Elzbieta Katarzyna Jagusztyn-KrynickaPaula Roszczenko
Oct 19, 2007·Expert Review of Proteomics·Giulia BernardiniAnnalisa Santucci
Mar 14, 2009·The Surgical Clinics of North America·Barbara Haas, Avery B Nathens
Nov 30, 2007·Journal of Microscopy·Philip SerwerGary A Griess
Apr 2, 2016·Vaccine·Andrew C SteerPierre R Smeesters
Apr 26, 2013·Vaccine·James B DaleAna Maria Henao-Restrepo
Oct 1, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annemarie BoleijHarold Tjalsma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.